BioAtla, Inc. 8-K Report: Key Updates & Insights as of December 19, 2024

Based on the provided XML section of the financial report, the following key information can be extracted:

1. Company Information:

• Name: BioAtla, Inc.
• CIK (Central Index Key): 0001826892
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-39787
• EIN (Employer Identification Number): 85-1922320
• Address: 11085 Torreyana Road, San Diego, CA 92121
• Phone Number: 858-558-0708

2. Filing Information:

• Form Type: 8-K (Current Report)
• Filing Date: December 19, 2024
• Period Covered: December 19, 2024 (indicating the report is likely for a specific event occurring on this date)

3. Stock Information:

• Common Stock Par Value: $0.0001 per share
• Stock Ticker: BCAB
• Exchange: NASDAQ

4. Context:

• The report references a specific schema (bcab-20241219.xsd) which may provide additional structure or context to the filing.

Insights:

• BioAtla, Inc. is actively listed on NASDAQ under the ticker BCAB, suggesting it is a public company that must comply with SEC regulations, including filing 8-K reports to disclose material events.
• The filing date and period of the report coincide, indicating it may pertain to a significant event or change that occurred on the date of the filing.
• The minimum par value of the stock suggests a potentially low-cost entry point for investors.

This information is crucial for stakeholders, including investors and analysts, to assess the company's current status, compliance with regulatory requirements, and potential investment opportunities.